Digital health is now at the forefront of deal activity in the life sciences and health care sector. The acquisition earlier this week by Johnson & Johnson subsidiary Apsis of France-based Orthotaxy, a software developer at the cutting edge of robotic-assisted orthopedic surgery, and the $118 million equity funding announced earlier today of privately held prostate surgery robotics company Procept BioRobotics, are just the latest in a series of digital health transactions that are transforming the life sciences and health care industries.
Last week, Swiss pharmaceutical giant Roche agreed to shell out a stunning $1.9 billion to acquire Flatiron Health, which has transformed a traditional electronic medical records business into an advanced digital platform providing data to optimize oncology-focused clinical trials through partnerships with the National Institutes of Health, the National Cancer Institute and hundreds of community oncology practices.
